Stay Ahead of Market & Policy Shifts
Financial & Policy Research Insights
Sector: Healthcare
Advisory Committee’s Split Decision on Biogen’s Tofersen
Policy & Legal, Research
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read more
Mitigation Expectations for Medicare Advantage Rate Notice
Policy & Legal, Research
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key
Fundamental, Research
How European Pharma fared versus consensus estimates...
Read more
Glaukos (GKOS): Pipeline Policy Pathway
Policy & Legal, Research
Following Glaukos’ (GKOS) earnings report, attention now turns to the regulatory...
Read more
Axonics (AXNX): Competition Coding Questions
Policy & Legal, Research
AXNX competitive pressures manageable following AMA disclosure...
Read moreShockwave (SWAV): Volatility Ahead?
Policy & Legal, Research
No more than 50% odds to CMS forestalling an implied facility cut of 25%+ for SWAV's IVL procedures...
Read more
Health Care: MedTech Companies Poised for Widening Operating Margins
Fundamental, Research
Recent earnings calls point to supply chain improvements...
Read more
Johnson & Johnson (JNJ): Texas Two-Step Takes a Spill
Policy & Legal, Research
Johnson & Johnson (JNJ: Talc Bankruptcy Opinion and Implications
Read more
ENSG, BKD, OHI, SBRA: Two Key SNF Headwinds Amassing This Spring
Policy & Legal, Research
Skilled nursing facilities face two key headwinds in ongoing recovery...
Read more
Biopharma: The CAR-T Party is Getting Crowded
Fundamental, Research
Biopharma companies building out portfolios of candidates targeting blood cancers...
Read more